Conducting Oncology Clinical Trials for Regulatory Approval Conference

Baltimore, MD

As diagnostic tests become more complex, effective and targeted testing opportunities for physicians and patients, the challenges in assuring regulatory approval for these products increases in tandem. The diversity in the manner of test development and commercialization results in a difficult regulatory environment, and the rapid rate of new innovation has left the FDA and other regulators around the world challenged to keep pace with innovation. As regulatory agencies work to create new standards to assure the efficacy and safety of new diagnostic tests, they are increasing the amount and longevity of clinical research studies to support the utility and effectiveness of each new product. This conference program will bring together regulators as well as industry experts who will share the challenges that they have faced in bringing new technologies to the market, as well as the strategies they have used to navigate through an uncertain regulatory environment.

Further Information: http://www.q1productions.com/eventPages/event_LSCONF-2034.php